Cargando…
Targeted inhibition of glutaminase as a potential new approach for the treatment of NF1 associated soft tissue malignancies
Many cancer cells rely on glutamine as the source of carbon molecules to feed the biosynthetic pathways and are often addicted to glutaminolysis. Inhibitors of glutaminase activity have gained attention in the last few years due to their anti-proliferative effect and ability to induce apoptosis in s...
Autores principales: | Sheikh, Tahir N., Patwardhan, Parag P., Cremers, Serge, Schwartz, Gary K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706855/ https://www.ncbi.nlm.nih.gov/pubmed/29212209 http://dx.doi.org/10.18632/oncotarget.21573 |
Ejemplares similares
-
Targeting glutaminase and mTOR
por: Tanaka, Kazuhiro, et al.
Publicado: (2015) -
Targeting glutaminase to starve lymphoma cells
por: Dumontet, Charles
Publicado: (2022) -
Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer
por: Udupa, Sunag, et al.
Publicado: (2019) -
The oncogenic transcription factor c-Jun regulates glutaminase expression and sensitizes cells to glutaminase-targeted therapy
por: Lukey, Michael J., et al.
Publicado: (2016) -
Dendrimer-conjugated glutaminase inhibitor selectively targets microglial glutaminase in a mouse model of Rett syndrome
por: Khoury, Elizabeth Smith, et al.
Publicado: (2020)